These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
303 related articles for article (PubMed ID: 27161971)
1. Health Care Segregation, Physician Recommendation, and Racial Disparities in BRCA1/2 Testing Among Women With Breast Cancer. McCarthy AM; Bristol M; Domchek SM; Groeneveld PW; Kim Y; Motanya UN; Shea JA; Armstrong K J Clin Oncol; 2016 Aug; 34(22):2610-8. PubMed ID: 27161971 [TBL] [Abstract][Full Text] [Related]
2. Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer. Armstrong K; Micco E; Carney A; Stopfer J; Putt M JAMA; 2005 Apr; 293(14):1729-36. PubMed ID: 15827311 [TBL] [Abstract][Full Text] [Related]
3. Are physician recommendations for BRCA1/2 testing in patients with breast cancer appropriate? A population-based study. McCarthy AM; Bristol M; Fredricks T; Wilkins L; Roelfsema I; Liao K; Shea JA; Groeneveld P; Domchek SM; Armstrong K Cancer; 2013 Oct; 119(20):3596-603. PubMed ID: 23861169 [TBL] [Abstract][Full Text] [Related]
4. Racial/Ethnic Differences in Patients' Selection of Surgeons and Hospitals for Breast Cancer Surgery. Freedman RA; Kouri EM; West DW; Keating NL JAMA Oncol; 2015 May; 1(2):222-30. PubMed ID: 26181027 [TBL] [Abstract][Full Text] [Related]
5. Prevalence and predictors of BRCA1 and BRCA2 mutations in a population-based study of breast cancer in white and black American women ages 35 to 64 years. Malone KE; Daling JR; Doody DR; Hsu L; Bernstein L; Coates RJ; Marchbanks PA; Simon MS; McDonald JA; Norman SA; Strom BL; Burkman RT; Ursin G; Deapen D; Weiss LK; Folger S; Madeoy JJ; Friedrichsen DM; Suter NM; Humphrey MC; Spirtas R; Ostrander EA Cancer Res; 2006 Aug; 66(16):8297-308. PubMed ID: 16912212 [TBL] [Abstract][Full Text] [Related]
6. BRCA1/2 testing among young women with breast cancer in Massachusetts, 2010-2013: An observational study using state cancer registry and All-Payer claims data. Pace LE; Ayanian JZ; Wolf RE; Knowlton R; Gershman ST; Hawkins SS; Keating NL Cancer Med; 2022 Jul; 11(13):2679-2686. PubMed ID: 35312162 [TBL] [Abstract][Full Text] [Related]
7. A high frequency of BRCA mutations in young black women with breast cancer residing in Florida. Pal T; Bonner D; Cragun D; Monteiro AN; Phelan C; Servais L; Kim J; Narod SA; Akbari MR; Vadaparampil ST Cancer; 2015 Dec; 121(23):4173-80. PubMed ID: 26287763 [TBL] [Abstract][Full Text] [Related]
8. Residential Racial Segregation and Disparities in Breast Cancer Presentation, Treatment, and Survival. Poulson MR; Beaulieu-Jones BR; Kenzik KM; Dechert TA; Ko NY; Sachs TE; Cassidy MR Ann Surg; 2021 Jan; 273(1):3-9. PubMed ID: 32889878 [TBL] [Abstract][Full Text] [Related]
9. Increased uptake of BRCA1/2 genetic testing among African American women with a recent diagnosis of breast cancer. Susswein LR; Skrzynia C; Lange LA; Booker JK; Graham ML; Evans JP J Clin Oncol; 2008 Jan; 26(1):32-6. PubMed ID: 18165638 [TBL] [Abstract][Full Text] [Related]
10. Germline BRCA Mutation Rates in Latina Women Presenting for Gynecologic Oncology Care. Hong L; Gonzalez R; Unternaehrer J; Ioffe Y Gynecol Obstet Invest; 2020; 85(3):214-221. PubMed ID: 32203957 [TBL] [Abstract][Full Text] [Related]
11. Racial disparities in BRCA testing and cancer risk management across a population-based sample of young breast cancer survivors. Cragun D; Weidner A; Lewis C; Bonner D; Kim J; Vadaparampil ST; Pal T Cancer; 2017 Jul; 123(13):2497-2505. PubMed ID: 28182268 [TBL] [Abstract][Full Text] [Related]
12. What Black Women Know and Want to Know About Counseling and Testing for BRCA1/2. Adams I; Christopher J; Williams KP; Sheppard VB J Cancer Educ; 2015 Jun; 30(2):344-52. PubMed ID: 25301325 [TBL] [Abstract][Full Text] [Related]
13. Predictors of BRCA1/2 genetic testing among Black women with breast cancer: a population-based study. Jones T; McCarthy AM; Kim Y; Armstrong K Cancer Med; 2017 Jul; 6(7):1787-1798. PubMed ID: 28627138 [TBL] [Abstract][Full Text] [Related]
14. Factors associated with genetic counseling and BRCA testing in a population-based sample of young Black women with breast cancer. Cragun D; Bonner D; Kim J; Akbari MR; Narod SA; Gomez-Fuego A; Garcia JD; Vadaparampil ST; Pal T Breast Cancer Res Treat; 2015 May; 151(1):169-76. PubMed ID: 25868867 [TBL] [Abstract][Full Text] [Related]
15. Underutilization of BRCA1/2 testing to guide breast cancer treatment: black and Hispanic women particularly at risk. Levy DE; Byfield SD; Comstock CB; Garber JE; Syngal S; Crown WH; Shields AE Genet Med; 2011 Apr; 13(4):349-55. PubMed ID: 21358336 [TBL] [Abstract][Full Text] [Related]
16. Frequency of breast cancer attributable to BRCA1 in a population-based series of American women. Newman B; Mu H; Butler LM; Millikan RC; Moorman PG; King MC JAMA; 1998 Mar; 279(12):915-21. PubMed ID: 9544765 [TBL] [Abstract][Full Text] [Related]
17. Reducing Disparities in Receipt of Genetic Counseling for Underserved Women at Risk of Hereditary Breast and Ovarian Cancer. Sutton AL; Hurtado-de-Mendoza A; Quillin J; Rubinsak L; Temkin SM; Gal T; Sheppard VB J Womens Health (Larchmt); 2020 Aug; 29(8):1131-1135. PubMed ID: 31794334 [No Abstract] [Full Text] [Related]
18. Racial differences in definitive breast cancer therapy in older women: are they explained by the hospitals where patients undergo surgery? Keating NL; Kouri E; He Y; Weeks JC; Winer EP Med Care; 2009 Jul; 47(7):765-73. PubMed ID: 19536008 [TBL] [Abstract][Full Text] [Related]
19. Physicians' experiences with BRCA1/2 testing in community settings. Keating NL; Stoeckert KA; Regan MM; DiGianni L; Garber JE J Clin Oncol; 2008 Dec; 26(35):5789-96. PubMed ID: 19001322 [TBL] [Abstract][Full Text] [Related]
20. Worry about racial discrimination: A missing piece of the puzzle of Black-White disparities in preterm birth? Braveman P; Heck K; Egerter S; Dominguez TP; Rinki C; Marchi KS; Curtis M PLoS One; 2017; 12(10):e0186151. PubMed ID: 29020025 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]